site stats

Ioanna gouni-berthold

WebTitle:APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia Volume: 25 Issue: 13 Author(s): Joel Schmitz and Ioanna Gouni-Berthold* Affiliation: Polyclinic for Endocrinology, Diabetes and Preventive Medicine (PEDP), University of Cologne, Kerpener Str. 62, 50937 Cologne,Germany WebIoanna GOUNI-BERTHOLD Professor MD, Professor Dr. University of Cologne, Köln UOC Center for Endocrinology, Diabetology and Preventive Medicine (ZEDP) …

PCSK9 INHIBITION AND AORTIC STENOSIS IN THE FOURIER TRIAL

WebIoanna Gouni-Berthold is Professor of Internal Medicine at the University of Cologne, Germany and senior registrar at the Polyclinic for Endocrinology, Diabetes and … WebProf. Dr. Ioanna Gouni-Berthold. Leiterin der Studienambulanz für Fettstoffwechselstörungen. Oberärztin. Fachärztin für Innere Medizin, Endokrinologie & … c sharp string to float https://fourseasonsoflove.com

Effect of Policosanol on Lipid Levels Among Patients With ...

Web25 apr. 2024 · RESEARCH ARTICLE The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes Samadhi Aparicio-Siegmund,1 Yvonne Garbers,2 Charlotte M. Flynn,1 Georg H. Waetzig,3 Ioanna Gouni-Berthold,4 Wilhelm Krone,4 Heiner K. Berthold,5 Matthias Laudes,6 Stefan Rose-John,1 and Christoph Garbers7 1Institute … Web16 nov. 2024 · PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects. Julius L. Katzmann 1*, Ioanna Gouni-Berthold 2 and Ulrich Laufs 1. 1 Department of … Web开馆时间:周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 e.a. fischione instruments inc. - export pa

MDPI Article Reprints Order

Category:Ioanna Gouni-Berthold – mightymedic.org

Tags:Ioanna gouni-berthold

Ioanna gouni-berthold

PCSK9 Inhibition: Insights From Clinical Trials and Future …

WebItems in Highlights & Notes may not have been saved to Google Drive™ or Microsoft OneDrive™. Are you sure you want to logout? Web12 apr. 2024 · Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area.

Ioanna gouni-berthold

Did you know?

WebU.S. patent application number 16/646593 was filed with the patent office on 2024-08-27 for n4-modified cytidine nucleotides and their use.The applicant listed for this patent is VILNIUS UNIVERSITY. WebDr Sonu M. M. Bhaskar, MD PhD PD (Stroke/Neurology) FANA, is an award-winning clinician-scientist, board director and academic neurologist with a specialisation in vascular neurology & neuroradiology; and a researcher with a strong focus on global health, clinical neurology and health systems, with a proven track record in governance, policy-making, …

WebAdministration of APO (a)-LRx resulted in dose-dependent decreases in lipoprotein (a) levels, with mean percent decreases of 35% at a dose of 20 mg every 4 weeks, 56% at 40 mg every 4 weeks, 58% at 20 mg every 2 weeks, 72% at 60 mg every 4 weeks, and 80% at 20 mg every week, as compared with 6% with placebo (P values for the comparison with ... Web29 nov. 2024 · Prof. Dr. Ioanna Gouni-Berthold, Leiterin der Studienambulanz für Fettstoffwechselstörungen in der Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin an der Uniklinik Köln, ist für den Zeitraum 2024 bis 2024 in den Vorstand der Internationalen Atherosklerose-Gesellschaft (IAS) gewählt worden.

WebPCSK9 Antibodies for the Treatment of Hypercholesterolemia by: Ioanna Gouni-Berthold, et al. Published: (2014-12-01) PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects by: Yan-yan Li, et al. Published: (2024-11-01) PCSK9 inhibitors as a therapy for hypercholesterolemia by ... Web13 feb. 2024 · In patients with atherosclerotic cardiovascular disease, long-term achievement of lower LDL-C levels, down to <20 mg/dL (<0.5 mmol/L), was associated with a lower risk of cardiovascular outcomes with no significant safety concerns. BACKGROUND Low-density lipoprotein cholesterol (LDL-C) level is a well-established risk factor for …

Web12 apr. 2024 · Erhöhte Lp(a)-Konzentrationen sind kausal mit einem erhöhten kardiovaskulären Risiko assoziiert. Es steht weder eine medikamentöse noch eine sonstige Behandlung zur Verfügung, die selektiv die Lp(a)-Konzentration verringert.

WebAnticipating social incentives recruits alpha-beta oscillations in the human substantia nigra and invigorates behavior across the life span. ea fish explorerWeb30 mrt. 2024 · Ioanna Gouni-Berthold, Henrik Kjærulf Jensen, Sadberk Lale Tokgozoglu, François Mach, Kurt Huber, Zbigniew Gaciong, Basil S. Lewis, Francois Schiele, Johan Wouter Jukema, Terje Pedersen, Robert Giugliano, and ; Marc Steven Sabatine; Brian Bergmark. Search for more papers by this author , ea fish returnsWeb16 nov. 2024 · These insights motivated the search for strategies to pharmacologically inhibit PCSK9. In an exemplary rapid development, fully human monoclonal antibodies … ea fish databaseWeb20 apr. 2024 · Prof. Dr. Ioanna Gouni-Berthold, Leiterin der Studienambulanz für Fettstoffwechselstörungen in der Poliklinik für Endokrinologie, Diabetologie und … e a firstWebProfessor Ioanna Gouni-Berthold is an Internist, Endocrinologist and head of the Lipid Research Clinic at at the Polyclinic for Endocrinology, Diabetes and Preventive Medicine … c sharp string to integerWebIoanna Gouni-Berthold 1 , Heiner K Berthold Affiliation 1 University of Cologne, Center of Endocrinology, Diabetes and Preventive Medicine, Cologne, Germany. … ea fish developmentWeb26 aug. 2016 · Ioanna Gouni-Berthold 5, Günther Silbernagel 6, Alexander Dressel 1, Tanja B. Grammer 7, Ulf Landmesser 8, Hans Dieplinger 9, Eberhard Windler 1,10 & … Ulrich Laufs 11 Show authors. American Journal of Cardiovascular Drugs volume 16, pages 475–476 (2016)Cite this article eafit bases bibliograficas